Laura Vance
Family Medicine · Bolivar, MONPI 1225050784
Payments from drug & device makers
Across 277 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$588
- Novo Nordisk$584
- Pfizer$542
- Lilly USA, LLC$395
- AstraZeneca$385
- GSK$240
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,600100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $588 |
| Novo Nordisk | 32 | $584 |
| Pfizer | 48 | $542 |
| Lilly USA, LLC | 25 | $395 |
| AstraZeneca | 19 | $385 |
| GSK | 16 | $240 |
| Eisai Inc. | 9 | $190 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $175 |
| Amgen | 11 | $170 |
| Merck | 10 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $108 |
| Abbott | 5 | $97 |
| Lundbeck LLC | 3 | $90 |
| Globus Medical | 2 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Novartis | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 5 | $68 |
| Exact Sciences | 4 | $68 |
| Radius Health, Inc. | 2 | $57 |
| Alkermes, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $50 |
| Dexcom, Inc. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Bayer | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
How this compares
$4,601 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 214 | $228,905 |
| OzempicSemaglutide | 179 | $222,585 |
| IngrezzaValbenazine Tosylate | 24 | $199,252 |
| EliquisApixaban | 155 | $165,767 |
| MounjaroTirzepatide | 76 | $122,990 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $115,692 |
| LinzessLinaclotide | 58 | $65,877 |
| XareltoRivaroxaban | 47 | $47,077 |
| FarxigaDapagliflozin Propanediol | 46 | $41,399 |
| TrulicityDulaglutide | 28 | $38,372 |
| MyrbetriqMirabegron | 26 | $32,974 |
| RybelsusSemaglutide | 22 | $31,809 |
| UbrelvyUbrogepant | 19 | $25,553 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $25,040 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $24,094 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $584 | $254,394201 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $242,744240 claims |
| PfizerEliquis | $542 | $165,767155 claims |
| Lilly USA, LLCMounjaro, Trulicity | $395 | $161,363104 claims |
| GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Incruse Ellipta | $240 | $145,041213 claims |
| AbbVieLinzess, Ubrelvy, Qulipta | $588 | $115,01590 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $385 | $74,362108 claims |
| Johnson & JohnsonXarelto | $35 | $47,07747 claims |
| Astellas Pharma US IncMyrbetriq | $44 | $32,97426 claims |
| MerckJanuvia | $142 | $14,51611 claims |
| NovartisEntresto | $74 | $13,91230 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Bolivar
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.